Congratulations to Adi Narahari, who was recently awarded an NIH F30 – Ruth L. Kirschstein National Research Service Award

Adi Narahari was recently awarded an NIH F30, an Individual Predoctoral Fellowship for MD/PhD students from the National Cancer Institute (NCI), which began on 12/1/18.  Adi is a Pharmacology degree candidate in lab of Dr. Douglas Bayliss.  He is  studying the involvement of Pannexin-1 channels in chemotherapy-induced neuropathic pain and Pannexin-1 channel activation properties.